| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director | Common Stock | 54,734 | $430,209 | $7.86 | 18 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | 18 Jun 2025 | 2 | $0 | 4 | Director | 18 Jul 2025, 16:05 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 13 Jun 2024 | 2 | +$70,011 | 4 | Director | 20 Jun 2024, 16:10 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 22 Jun 2023 | 2 | +$70,012 | 4 | Director | 26 Jun 2023, 19:47 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 13 Jun 2022 | 2 | +$69,924 | 4 | Director | 15 Jun 2022, 21:07 |
| RCKT | ROCKET PHARMACEUTICALS, INC. | 14 Jun 2021 | 2 | +$69,990 | 4 | Director | 16 Jun 2021, 20:19 |